New Nordic Healthbrands (OM:NNH) - Share price, News & Analysis

NNH fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	4/6
Financial Health	5/6
Dividends	2/6

NNH Stock Overview

New Nordic Healthbrands AB (publ) develops and markets dietary supplements, natural medicines, and cosmetic products in Sweden.

Rewards

Price-To-Earnings ratio (8.6x) is below the Swedish market (16x)

Earnings grew by 19.9% over the past year

Risk Analysis

High level of non-cash earnings

Dividend of 4.24% is not well covered by earnings

Volatile share price over the past 3 months

Does not have a meaningful market cap (SEK183M)

New Nordic Healthbrands Competitors

Price History & Performance

Summary of all time highs, changes and price drops for New Nordic Healthbrands
Historical stock prices
Current Share Price	kr29.50
52 Week High	kr110.00
52 Week Low	kr29.40
Beta	0.66
1 Month Change	-17.14%
3 Month Change	-41.47%
1 Year Change	-64.88%
3 Year Change	-56.49%
5 Year Change	10.08%
Change since IPO	-45.87%

Recent News & Updates

May 20

New Nordic Healthbrands (STO:NNH) Has A Pretty Healthy Balance Sheet

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Apr 29

Capital Investment Trends At New Nordic Healthbrands (STO:NNH) Look Strong

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...

Shareholder Returns

	NNH	SE Personal Products	SE Market
7D	-8.4%	-4.1%	-1.0%
1Y	-64.9%	-37.0%	-23.6%

Return vs Industry: NNH underperformed the Swedish Personal Products industry which returned -31.8% over the past year.

Return vs Market: NNH underperformed the Swedish Market which returned -20.4% over the past year.

Price Volatility

Is NNH's price volatile compared to industry and market?
NNH volatility
NNH Average Weekly Movement	9.4%
Personal Products Industry Average Movement	5.4%
Market Average Movement	7.4%
10% most volatile stocks in SE Market	12.2%
10% least volatile stocks in SE Market	4.7%

Stable Share Price: NNH is more volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: NNH's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

Founded	Employees	CEO	Website
1990	72	Karl Kristian Jensen	https://www.newnordic.se

New Nordic Healthbrands AB (publ) develops and markets dietary supplements, natural medicines, and cosmetic products in Sweden. The company provides vitality products for immune system. It offers its products under Hair Volume, Skin Care, and New Nordic brand names.

New Nordic Healthbrands Fundamentals Summary

How do New Nordic Healthbrands's earnings and revenue compare to its market cap?
NNH fundamental statistics
Market Cap	kr182.76m
Earnings (TTM)	kr21.30m
Revenue (TTM)	kr514.85m

8.6x

P/E Ratio

0.4x

P/S Ratio

Is NNH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
NNH income statement (TTM)
Revenue	kr514.85m
Cost of Revenue	kr164.80m
Gross Profit	kr350.05m
Other Expenses	kr328.75m
Earnings	kr21.30m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Jul 29, 2022

Earnings per share (EPS)	3.44
Gross Margin	67.99%
Net Profit Margin	4.14%
Debt/Equity Ratio	20.3%

How did NNH perform over the long term?

See historical performance and comparison

Dividends

4.2%

Current Dividend Yield

36%

Payout Ratio

We’ve recently updated our valuation analysis.

Valuation

Is NNH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NNH?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for NNH. This is calculated by dividing NNH's market cap by their current preferred multiple.
What is NNH's n/a Ratio?
n/a Ratio	0x
n/a	n/a
Market Cap	kr182.76m

NNH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.4x
Enterprise Value/EBITDA	6.7x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does NNH's PE Ratio compare to its peers?

NNH PE Ratio vs Peers

The above table shows the PE ratio for NNH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	PE	Estimated Growth	Market Cap
Peer Average	114.9x

Forward PE

Price-To-Earnings vs Peers: NNH is good value based on its Price-To-Earnings Ratio (8.6x) compared to the peer average (114.9x).

Price to Earnings Ratio vs Industry

How does NNH's PE Ratio compare vs other companies in the Personal Products Industry?

Price-To-Earnings vs Industry: NNH is good value based on its Price-To-Earnings Ratio (8.6x) compared to the European Personal Products industry average (22.3x)

Price to Earnings Ratio vs Fair Ratio

What is NNH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NNH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	8.6x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate NNH's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of NNH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NNH (SEK29.5) is trading above our estimate of fair value (SEK26.19)

Significantly Below Fair Value: NNH is trading above our estimate of fair value.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate NNH's PEG Ratio to determine if it is good value.

Discover undervalued companies

Future Growth

How is New Nordic Healthbrands forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

8.7%

Forecasted Household industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as New Nordic Healthbrands has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

Check out New Nordic Healthbrands's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
New Nordic Healthbrands competitive advantages and company strategy can generally be found in its financial reports archived here.

Past Performance

How has New Nordic Healthbrands performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

10.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: NNH has a high level of non-cash earnings.

Growing Profit Margin: NNH's current net profit margins (4.1%) are higher than last year (3.9%).

Past Earnings Growth Analysis

Earnings Trend: NNH's earnings have grown by 10.6% per year over the past 5 years.

Accelerating Growth: NNH's earnings growth over the past year (19.9%) exceeds its 5-year average (10.6% per year).

Earnings vs Industry: NNH earnings growth over the past year (19.9%) exceeded the Personal Products industry 8.7%.

Return on Equity

High ROE: NNH's Return on Equity (17.7%) is considered low.

Discover strong past performing companies

Financial Health

How is New Nordic Healthbrands's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: NNH's short term assets (SEK228.2M) exceed its short term liabilities (SEK114.7M).

Long Term Liabilities: NNH's short term assets (SEK228.2M) exceed its long term liabilities (SEK3.4M).

Debt to Equity History and Analysis

Debt Level: NNH's net debt to equity ratio (10.4%) is considered satisfactory.

Reducing Debt: NNH's debt to equity ratio has reduced from 67.4% to 20.3% over the past 5 years.

Debt Coverage: NNH's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: NNH's interest payments on its debt are well covered by EBIT (48.3x coverage).

Balance Sheet

Discover healthy companies

Dividend

What is New Nordic Healthbrands's current dividend yield, its reliability and sustainability?

Dividend Score

2/6

Dividend Score 2/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

4.24%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: NNH's dividend (4.24%) is higher than the bottom 25% of dividend payers in the Swedish market (1.65%).

High Dividend: NNH's dividend (4.24%) is low compared to the top 25% of dividend payers in the Swedish market (5.34%).

Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, NNH has been paying a dividend for less than 10 years.

Growing Dividend: NNH's dividend payments have increased, but the company has only paid a dividend for 6 years.

Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (36.4%), NNH's dividend payments are well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: NNH is paying a dividend but the company has no free cash flows.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.3yrs

Average management tenure

CEO

Karl Kristian Jensen (59 yo)

32.42yrs

Tenure

Mr. Karl Kristian Bergman Jensen, VD co-founded New Nordic Health Brands AB (publ) in 1990 and has been its Chief Executive Officer & Director since 2006. Prior to that, Mr. Jensen served as International...

Leadership Team

Experienced Management: NNH's management team is considered experienced (2.3 years average tenure).

Board Members

Experienced Board: NNH's board of directors are seasoned and experienced ( 16.4 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: NNH insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/06/23 00:00
End of Day Share Price	2022/06/23 00:00
Earnings	2021/12/31
Annual Earnings	2021/12/31